Top Markets
#1 Black Phoenix Black Phoenix +357.53%
#2 Islamic Coin Islamic Coin +158.14%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +19.93%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.49%
#6 Victoria VR Victoria VR +7.35%
#7 Pons Pons +6.63%
#8 COTI COTI +6.01%
#9 Movement Movement +5.28%
#10 Palladium Network Palladium Network +5.16%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIAP
Classement en actions #41780
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily... VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor: Currently in preclinical development for treating type 2 diabetes, with promising potential for weight management and other lipid disorders. VIA-2291: A 5-Lipoxygenase inhibitor that has successfully completed its third Phase 2 clinical trial. Its purpose is to target atherosclerotic plaque, a significant contributor to heart attacks, strokes, and various other vascular diseases. VIA Pharmaceuticals has also forged two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. These collaborations pertain to their THR beta agonist program and several compounds from their preclinical DGAT1 metabolic disorders initiative. Established in 2004, the company's headquarters are located in San Francisco, California.
Prix de l'action
$0.0005
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$10.28K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange VIA Pharmaceuticals, Inc. (VIAP)

Catégorie

Healthcare
Le prix VIAP avec la capitalisation boursière de B
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
VIAP
$0.0005
Capitalisation boursière de VIA Pharmaceuticals, Inc.(VIAP)
Capitalisation boursière: $10.28K
En August 2026, VIA Pharmaceuticals, Inc. a une capitalisation boursière de $10.28K. Cela fait de VIA Pharmaceuticals, Inc. la 41780th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de VIA Pharmaceuticals, Inc. du 2007 au 2026
VIAP par rapport au top 5 des plus populaires stocks
Prix pour VIAP L’actif B La capitalisation boursière de B Résultats
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$261,862 $10.28K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +52,372,404,414.06%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$215,166 $10.28K
Apple Inc. Apple Inc.
AAPL
$4.423T +43,033,283,329.69%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$202,372 $10.28K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +40,474,456,550.28%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$178,194 $10.28K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +35,638,883,419.80%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$140,638 $10.28K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +28,127,529,770.61%